Skip to main content
IOL Chemicals & Pharmaceuticals Ltd logo

IOL Chemicals & Pharmaceuticals Ltd — Investor Relations & Filings

Ticker · IOLCP ISIN · INE485C01029 LEI · 335800U5FXFDI8H3DT63 BSE.NS Manufacturing
Open in API
Filings indexed 1,010 across all filing types
Latest filing 2026-05-20 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS IOLCP

About IOL Chemicals & Pharmaceuticals Ltd

https://www.iolcp.com/

IOL Chemicals and Pharmaceuticals Ltd is a manufacturer of Active Pharmaceutical Ingredients (APIs) and specialty chemicals. The company is the world's largest producer of Ibuprofen, maintaining a significant global market share through extensive vertical integration. Its pharmaceutical portfolio includes key therapeutic products such as Metformin, Fenofibrate, Clopidogrel, and Pantoprazole. In the specialty chemicals segment, it produces Ethyl Acetate, Iso Butyl Benzene, and Acetyl Chloride, catering to diverse industrial applications. The company operates advanced manufacturing facilities with international regulatory approvals, including the USFDA and EDQM. It focuses on cost-efficient production and sustainable practices to serve a global clientele across the pharmaceutical and chemical sectors.

Recent filings

Filing Released Lang Actions
General Updates
Interim / Quarterly Report Classification · 85% confidence The document is a SEBI Listing Regulation 30 & 33 filing by IOL Chemicals & Pharmaceuticals, titled “Outcome of the Board Meeting and submission of Audited Financial Results for the quarter and year ended 31st March 2026.” It includes audited standalone and consolidated financial results tables, an auditor’s report, and related board decisions (AGM date, plant installation approvals). This is not a full annual report (10-K) nor a simple earnings highlight release (ER) but rather the substantive fourth-quarter and full-year audited results with detailed figures and disclosures, fitting the definition of an Interim/Quarterly Report under category IR. FY 2026
2026-05-20 English
Fixed 39th Annual General Meeting of the Company and Book Closure of Register of Members
Audit Report / Information Classification · 90% confidence The document is filed under SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 as an outcome of the Board meeting and submission of Audited Standalone & Consolidated Financial Results for the quarter and year ended 31 March 2026. It contains the full Independent Auditor’s Report on the audit of the quarterly and annual standalone financial results, together with the detailed audited financial statements. This is not merely a high-level earnings release or investor presentation, nor a full annual report with MD&A; rather it is the standalone audit report and audited financial results. Under the provided taxonomy, this most closely matches “Audit Report / Information (AR)” which covers standalone audit reports and applied accounting principles (excluding a full annual report). FY 2026
2026-05-20 English
Outcome of the Board Meeting and submission of Audited Financial Results for the quarter and year ended 31st March 2026
Interim / Quarterly Report Classification · 90% confidence The document is a formal Board meeting outcome filed under SEBI Listing Regulations, providing the audited standalone and consolidated financial results for the quarter and year ended 31 March 2026, together with the full financial statements (P&L, balance lines) and the Independent Auditor’s Report. It is not merely an announcement that reports are published (so not RPA) nor just key highlights (so not an ER), and it is not a full Annual Report (10-K). It contains substantive financial statements for a period shorter than a full fiscal year (the quarter) and is a true filing of interim/quarterly results. This matches the definition of an Interim/Quarterly Report (IR). FY 2026
2026-05-20 English
Outcome of Board Meeting and submission of Audited Financial Results
Interim / Quarterly Report Classification · 85% confidence The document is a stock exchange filing under SEBI Listing Regulations notifying the outcome of a board meeting and submitting the Audited Standalone & Consolidated Financial Results for the quarter and year ended 31 March 2026. It includes the auditor’s report (Annexure 1) and full financial result tables with actual data (revenues, expenses, profits), far beyond mere highlights. It is not a full Annual Report, nor just an earnings press release, but a comprehensive quarterly (and year-end) financial results disclosure. According to the definitions, this fits the “Interim / Quarterly Report” category. FY 2026
2026-05-20 English
Outcome of Board Meeting
Regulatory Filings Classification · 85% confidence The document is a formal compliance filing to the Indian stock exchanges under SEBI Listing Obligations (Regulation 30 & 33). It reports the outcome of the Board meeting and encloses the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, together with the independent auditor’s report. It is not a full annual report (10-K), nor solely an auditor’s report (AR), nor a full management discussion or proxy statement. It is a regulatory announcement of audited financial results under listing regulations, making it a general regulatory filing (RNS).
2026-05-20 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 75% confidence The document is an announcement under SEBI Listing Regulations informing the stock exchanges of the schedule for the Q4 FY26 investor/analyst conference call. It does not contain financial statements or a report itself, nor is it the transcript of the call. It is a compliance/regulatory notice pursuant to Reg 30 of the LODR, falling under general regulatory announcements that do not fit a more specific category. Therefore, it should be classified as a Regulatory Filing (RNS).
2026-05-18 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.